Health Canada issues warning on over-dosage morphine tablets
This article was originally published in Scrip
Executive Summary
Health Canada has issued a warning about ratio-Morphine SR tablets, as some may contain more morphine than indicated. Morphine SR 15mg, 30mg and 60mg tablets with above-stated doses of morphine, reported to be noticeably thicker than the regular tablets, were found to be on the Canadian market after US manufacturer KV Pharmaceutical received two complaints, prompting the Canadian distributor Ratiopharm to initiate a recall of the affected lots, with a separate communication being prepared for doctors and pharmacists. Patients currently using ratio-Morphine SR tablets of the affected doses are advised to contact their physician for an alternative and return products to a pharmacist for safe disposal. As of June 30th, no adverse reactions had been reported to Health Canada.